Literature DB >> 11665684

Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection.

M Bharadwaj, S R Burrows, J M Burrows, D J Moss, M Catalina, R Khanna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11665684     DOI： 10.1182/blood.v98.8.2588

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

1.  Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.

Authors:  B Neuhierl; R Feederle; W Hammerschmidt; H J Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

2.  CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.

Authors:  Patrick J Hanley; Jan J Melenhorst; Sarah Nikiforow; Phillip Scheinberg; James W Blaney; Gail Demmler-Harrison; C Russell Cruz; Sharon Lam; Robert A Krance; Kathryn S Leung; Caridad A Martinez; Hao Liu; Daniel C Douek; Helen E Heslop; Cliona M Rooney; Elizabeth J Shpall; A John Barrett; John R Rodgers; Catherine M Bollard
Journal:  Sci Transl Med       Date:  2015-04-29       Impact factor: 17.956

Review 3.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

4.  Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations.

Authors:  Joo Y Song; Stefania Pittaluga; Kieron Dunleavy; Nicole Grant; Therese White; Liuyan Jiang; Theresa Davies-Hill; Mark Raffeld; Wyndham H Wilson; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2015-02       Impact factor: 6.394

Review 5.  Viral-associated lymphoid proliferations.

Authors:  Stefania Pittaluga
Journal:  Semin Diagn Pathol       Date:  2013-03-26       Impact factor: 3.464

6.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

7.  Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis.

Authors:  Suzanne L Elliott; Andreas Suhrbier; John J Miles; Greg Lawrence; Stephanie J Pye; Thuy T Le; Andrew Rosenstengel; Tam Nguyen; Anthony Allworth; Scott R Burrows; John Cox; David Pye; Denis J Moss; Mandvi Bharadwaj
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

8.  Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.

Authors:  Tania Crough; Chrysa Fazou; Julissa Weiss; Scott Campbell; Miles P Davenport; Scott C Bell; Andrew Galbraith; Keith McNeil; Rajiv Khanna
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.

Authors:  P Höllsberg; H J Hansen; S Haahr
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.